Virpi Talman

2.1k total citations · 1 hit paper
45 papers, 1.6k citations indexed

About

Virpi Talman is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Virpi Talman has authored 45 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 9 papers in Surgery and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Virpi Talman's work include Protein Kinase Regulation and GTPase Signaling (14 papers), Computational Drug Discovery Methods (9 papers) and Congenital heart defects research (9 papers). Virpi Talman is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (14 papers), Computational Drug Discovery Methods (9 papers) and Congenital heart defects research (9 papers). Virpi Talman collaborates with scholars based in Finland, United States and United Kingdom. Virpi Talman's co-authors include Heikki Ruskoaho, Riikka Kivelä, Raimo K. Tuominen, Jari Yli‐Kauhaluoma, Gustav Boije af Gennäs, Elina Ekokoski, Jouni Hirvonen, Mónica P. A. Ferreira, Hélder A. Santos and Sini M. Kinnunen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Virpi Talman

42 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration

2016 689 citations Virpi Talman, Heikki Ruskoaho Cell and Tissue Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Virpi Talman Finland	17	833	576	372	234	219	45	1.6k
Khanh T. Nguyen United States	17	607 0.7×	305 0.5×	171 0.5×	141 0.6×	104 0.5×	40	1.4k
Jianye Yang China	23	744 0.9×	155 0.3×	416 1.1×	206 0.9×	259 1.2×	58	1.6k
Masanari Umemura Japan	21	672 0.8×	368 0.6×	126 0.3×	128 0.5×	117 0.5×	67	1.5k
Jonathan A. Stiber United States	23	1.5k 1.8×	533 0.9×	481 1.3×	103 0.4×	194 0.9×	37	2.3k
Byeong‐Wook Song South Korea	24	860 1.0×	184 0.3×	459 1.2×	145 0.6×	262 1.2×	81	1.8k
Claudio Muscari Italy	28	861 1.0×	247 0.4×	510 1.4×	264 1.1×	378 1.7×	91	2.0k
Shiming Liu China	24	1.0k 1.3×	292 0.5×	246 0.7×	133 0.6×	155 0.7×	73	2.0k
Jaap Rip Netherlands	20	585 0.7×	296 0.5×	180 0.5×	145 0.6×	406 1.9×	42	1.4k
Wenhong Xu China	23	970 1.2×	358 0.6×	95 0.3×	218 0.9×	188 0.9×	54	1.9k
Xiaowei Wang China	20	528 0.6×	281 0.5×	258 0.7×	100 0.4×	82 0.4×	70	1.4k

Countries citing papers authored by Virpi Talman

Since Specialization

Citations

This map shows the geographic impact of Virpi Talman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virpi Talman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virpi Talman more than expected).

Fields of papers citing papers by Virpi Talman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virpi Talman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virpi Talman. The network helps show where Virpi Talman may publish in the future.

Co-authorship network of co-authors of Virpi Talman

This figure shows the co-authorship network connecting the top 25 collaborators of Virpi Talman. A scholar is included among the top collaborators of Virpi Talman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virpi Talman. Virpi Talman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bellahcene, Mohamed, Christopher L. Grigsby, Virpi Talman, et al.. (2025). Melt electrowritten medium chain length polyhydroxyalkanoate cardiac patches for Post-MI cardiac regeneration. Materials Today Bio. 34. 102256–102256.

Ruohonen, Saku, Zoltán Szabó, Minying Cai, et al.. (2025). Melanocortin 1 Receptor Regulates Pathological and Physiological Cardiac Remodeling. Journal of the American Heart Association. 14(4). e037961–e037961.

Ghimire, Bishwa, Béla Merkely, Anna M. Randi, et al.. (2024). Generation and characterisation of scalable and stable human pluripotent stem cell-derived microvascular-like endothelial cells for cardiac applications. Angiogenesis. 27(3). 561–582. 10 indexed citations

Kinnunen, Sini M., Alexandros Kiriazis, Jari Yli‐Kauhaluoma, et al.. (2024). Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound. Stem Cell Research & Therapy. 15(1). 5–5. 1 indexed citations

Kinnunen, Sini M., Mika J. Välimäki, Virpi Talman, et al.. (2024). Affinity chromatography reveals direct binding of the GATA4–NKX2-5 interaction inhibitor (3i-1000) with GATA4. Scientific Reports. 14(1). 8938–8938.

Ruohonen, Saku, Zoltán Szabó, Bishwa Ghimire, et al.. (2024). α-Melanocyte-stimulating hormone alleviates pathological cardiac remodeling via melanocortin 5 receptor. EMBO Reports. 25(4). 1987–2014. 1 indexed citations

Koivuniemi, Artturi, Henri Xhaard, Raimo K. Tuominen, et al.. (2023). Expanding the Paradigm of Structure-Based Drug Design: Molecular Dynamics Simulations Support the Development of New Pyridine-Based Protein Kinase C-Targeted Agonists. Journal of Medicinal Chemistry. 66(7). 4588–4602. 2 indexed citations

Torrieri, Giulia, Flavia Fontana, Virpi Talman, et al.. (2023). Macrophage Hitchhiking Nanoparticles for the Treatment of Myocardial Infarction: An In Vitro and In Vivo Study. Advanced Functional Materials. 33(34). 10 indexed citations

Chaudhari, Umesh, et al.. (2023). Genome-wide profiling of miRNA-gene regulatory networks in mouse postnatal heart development—implications for cardiac regeneration. Frontiers in Cardiovascular Medicine. 10. 1148618–1148618. 2 indexed citations

10.

Ruskoaho, Heikki, et al.. (2022). Transcriptomics reveal stretched human pluripotent stem cell-derived cardiomyocytes as an advantageous hypertrophy model. SHILAP Revista de lepidopterología. 2. 100020–100020. 4 indexed citations

11.

Nunn, Rebecca, et al.. (2021). Protein Kinase A–Mediated Effects of Protein Kinase C Partial Agonist 5-(Hydroxymethyl)Isophthalate 1a3 in Colorectal Cancer Cells. Journal of Pharmacology and Experimental Therapeutics. 380(1). 54–62. 2 indexed citations

12.

Kinnunen, Sini M., et al.. (2020). GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes. Archives of Toxicology. 94(6). 2113–2130. 15 indexed citations

13.

Ruskoaho, Heikki, et al.. (2020). Distinct Regulation of Cardiac Fibroblast Proliferation and Transdifferentiation by Classical and Novel Protein Kinase C Isoforms: Possible Implications for New Antifibrotic Therapies. Molecular Pharmacology. 99(2). 104–113. 9 indexed citations

14.

Jäntti, Maria, Jari Yli‐Kauhaluoma, Virpi Talman, et al.. (2019). Missing Selectivity of Targeted 4β-Phorbol Prodrugs Expected to be Potential Chemotherapeutics. ACS Medicinal Chemistry Letters. 11(5). 671–677. 7 indexed citations

15.

Talman, Virpi, Päivi Pöhö, Parisa Movahedi, et al.. (2018). Molecular Atlas of Postnatal Mouse Heart Development. Journal of the American Heart Association. 7(20). e010378–e010378. 73 indexed citations

16.

Sarajärvi, Timo, Maria Jäntti, Kaisa M. A. Paldanius, et al.. (2018). Protein kinase C -activating isophthalate derivatives mitigate Alzheimer's disease-related cellular alterations. Neuropharmacology. 141. 76–88. 13 indexed citations

17.

Talman, Virpi & Riikka Kivelä. (2018). Cardiomyocyte—Endothelial Cell Interactions in Cardiac Remodeling and Regeneration. Frontiers in Cardiovascular Medicine. 5. 101–101. 121 indexed citations

18.

Välimäki, Mika J., Sini M. Kinnunen, Gábor Földes, et al.. (2018). Stem cells are the most sensitive screening tool to identify toxicity of GATA4-targeted novel small-molecule compounds. Archives of Toxicology. 92(9). 2897–2911. 21 indexed citations

19.

Talman, Virpi & Heikki Ruskoaho. (2016). Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration. Cell and Tissue Research. 365(3). 563–581. 689 indexed citations breakdown →

20.

Talman, Virpi, Raimo K. Tuominen, Gustav Boije af Gennäs, Jari Yli‐Kauhaluoma, & Elina Ekokoski. (2011). C1 Domain-Targeted Isophthalate Derivatives Induce Cell Elongation and Cell Cycle Arrest in HeLa Cells. PLoS ONE. 6(5). e20053–e20053. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact